Overview

A Study of Ranolazine in ALS

Status:
RECRUITING

Trial end date:
2026-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.

Phase:

PHASE2

Details

Lead Sponsor:

Swathy Chandrashekhar, MBBS

Collaborator:

ALS Association

Treatments:

Ranolazine